Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 2006
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agentsEdson X Albuquerque, Edna F R Pereira, Yasco Aracava, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptorsMarek Samochocki, Anja Höffle, Andreas Fehrenbacher, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Bioorganic & Medicinal Chemistry|October 15, 2003
Design, synthesis and pharmacological profile of novel dopamine D2 receptor ligandsRicardo Menegatti, Anna C Cunha, Vítor F Ferreira, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 14, 2004
Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampusManickavasagon Alkondon, Edna F R Pereira, Ping Yu, et al.
Nature|May 5, 2016
NMDAR inhibition-independent antidepressant actions of ketamine metabolitesPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 24, 2019
Antidepressant-relevant concentrations of the ketamine metabolite (2<i>R</i>,6<i>R</i>)-hydroxynorketamine do not block NMDA receptor functionEric W Lumsden, Timothy A Troppoli, Scott J Myers, et al.
Pageof 6